15.86
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innoviva Inc | INVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 15.86 | 04:00:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 15.86 | USD |
Period:
Draw Mode:
Innoviva Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.10B | 69.49M | 26.04M | $ 336.79M | $ 311.16M | 2.03 | 4.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -758.00 | 10.70% |
Innoviva News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.09 | 16.43 | 15.345 | 15.76 | 745,319 | -0.23 | -1.43% |
| 1 Month | 17.38 | 17.8773 | 15.345 | 16.52 | 568,326 | -1.52 | -8.75% |
| 3 Months | 17.71 | 18.9699 | 15.345 | 16.97 | 565,412 | -1.85 | -10.45% |
| 6 Months | 13.26 | 18.9699 | 13.13 | 16.36 | 705,663 | 2.60 | 19.61% |
| 1 Year | 12.23 | 18.9699 | 10.92 | 14.57 | 657,967 | 3.63 | 29.68% |
| 3 Years | 19.75 | 20.54 | 7.58 | 13.50 | 703,582 | -3.89 | -19.7% |
| 5 Years | 10.76 | 20.54 | 7.58 | 13.86 | 801,164 | 5.10 | 47.4% |
Innoviva Description
| Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline. |